Heparin and warfarin anticoagulation intensity as predictors of recurrence after deep vein thrombosis or pulmonary embolism: a population-based cohort study
Heit et al.
Blood 2011;118:4992-4999.
ABSTRACT
| FULL TEXT
Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion
Guervil et al.
The Annals of Pharmacotherapy 2011;45:861-868.
ABSTRACT
| FULL TEXT
Inaccuracy of a "Spiked Curve" for Monitoring Unfractionated Heparin Therapy
Gausman and Marlar
Am J Clin Pathol 2011;135:870-876.
ABSTRACT
| FULL TEXT
Heparins: Clinical Use and Laboratory Monitoring
Hoffman
Lab Med 2010;41:621-626.
ABSTRACT
| FULL TEXT
Identifying Optimal Initial Infusion Rates for Unfractionated Heparin in Morbidly Obese Patients
Riney et al.
The Annals of Pharmacotherapy 2010;44:1141-1151.
ABSTRACT
| FULL TEXT
Evaluation of Bleeding Risk in Patients Exposed to Therapeutic Unfractionated or Low-Molecular-Weight Heparin: A Cohort Study in the Context of a Quality Improvement Initiative
Cossette et al.
The Annals of Pharmacotherapy 2010;44:994-1002.
ABSTRACT
| FULL TEXT
Weight-Based Argatroban Dosing Nomogram for Treatment of Heparin-Induced Thrombocytopenia
Ansara et al.
The Annals of Pharmacotherapy 2009;43:9-18.
ABSTRACT
| FULL TEXT
Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
Schulman et al.
Chest 2008;133:257S-298S.
ABSTRACT
| FULL TEXT
Subcutaneous unfractionated heparin vs low-molecular-weight heparin for acute thromboembolic disease: issues of efficacy and cost.
Carson
JAMA 2006;296:991-993.
FULL TEXT
How I treat venous thromboembolism in patients with cancer
Prandoni
Blood 2005;106:4027-4033.
ABSTRACT
| FULL TEXT
Anticoagulation Monitoring Part 2: Unfractionated Heparin and Low-Molecular-Weight Heparin
Spinler et al.
The Annals of Pharmacotherapy 2005;39:1275-1285.
ABSTRACT
| FULL TEXT
Antithrombotic Therapy for Venous Thromboembolic Disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
Buller et al.
Chest 2004;126:401S-428S.
ABSTRACT
| FULL TEXT
Challenges to the Effective Use of Unfractionated Heparin in the Hospitalized Management of Acute Thrombosis
Hylek et al.
Arch Intern Med 2003;163:621-627.
ABSTRACT
| FULL TEXT
Validation of a Weight-Based Nomogram for the Use of Intravenous Heparin in Transient Ischemic Attack or Stroke
Toth and Voll
Stroke 2002;33:670-674.
ABSTRACT
| FULL TEXT
Heparin and Low-Molecular-Weight Heparin Mechanisms of Action, Pharmacokinetics, Dosing, Monitoring, Efficacy, and Safety
Hirsh et al.
Chest 2001;119:64S-94S.
FULL TEXT
Antithrombotic Therapy for Venous Thromboembolic Disease
Hyers et al.
Chest 2001;119:176S-193S.
FULL TEXT
Low-Molecular-Weight Heparin vs Heparin in the Treatment of Patients With Pulmonary Embolism
Hull et al.
Arch Intern Med 2000;160:229-236.
ABSTRACT
| FULL TEXT
Venous thrombus stability during acute phase of therapy
Caps et al.
Vasc Med 1999;4:9-14.
ABSTRACT
aPTT in Heparinized Patients: Influence of the Interval Between Sampling and Testing
Rachakonda et al.
CLIN APPL THROMB HEMOST 1998;4:213-216.
ABSTRACT
The Importance of Initial Heparin Treatment on Long-term Clinical Outcomes
Shojania et al.
Arch Intern Med 1998;158:1270-1272.
FULL TEXT
Low-Molecular-Weight Heparin Therapy and Mortality
Valentine et al.
PERSPECT VASC SURG ENDOVASC THER 1998;9:99-108.
ABSTRACT
Relation Between the Time to Achieve the Lower Limit of the APTT Therapeutic Range and Recurrent Venous Thromboembolism During Heparin Treatment for Deep Vein Thrombosis
Hull et al.
Arch Intern Med 1997;157:2562-2568.
ABSTRACT
Effect of Weight, Sex, Age, Clinical Diagnosis, and Thromboplastin Reagent on Steady-state Intravenous Heparin Requirements
White et al.
Arch Intern Med 1997;157:2468-2472.
ABSTRACT
The Importance of Initial Heparin Treatment on Long-term Clinical Outcomes of Antithrombotic Therapy: The Emerging Theme of Delayed Recurrence
Hull et al.
Arch Intern Med 1997;157:2317-2321.
ABSTRACT
Is There a Relationship Between the Intensity of Heparin Treatment and Recurrent Thomboembolism?
Anand et al.
CLIN APPL THROMB HEMOST 1997;3:S64-S67.
ABSTRACT
Overview of Treatment of Venous Thromboembolism Based on Levels of Evidence
Hull and Pineo
CLIN APPL THROMB HEMOST 1997;3:S68-S71.
Treatment of Proximal Vein Thrombosis With Subcutaneous Low-Molecular-Weight Heparin vs Intravenous Heparin: An Economic Perspective
Hull et al.
Arch Intern Med 1997;157:289-294.
ABSTRACT
aPTT in Heparinized Plasma: Influence of Reagent, Acute-Phase Reaction, and Interval Between Sampling and Testing
Strekerud and Abildgaard
CLIN APPL THROMB HEMOST 1996;2:250-257.
ABSTRACT
The Effectiveness of Implementing the Weight-Based Heparin Nomogram as a Practice Guideline
Raschke et al.
Arch Intern Med 1996;156:1645-1649.
ABSTRACT
The Relation Between the Activated Partial Thromboplastin Time Response and Recurrence in Patients With Venous Thrombosis Treated With Continuous Intravenous Heparin
Anand et al.
Arch Intern Med 1996;156:1677-1681.
ABSTRACT
State-of-the-Art Review : Activated Partial Thromboplastin Time in Heparinized Plasma: Influence of Reagent, Acute-Phase Reaction, and Interval Between Sampling and Testing
Strekerud and Abildgaard
CLIN APPL THROMB HEMOST 1996;2:169-176.
ABSTRACT
Aging and Heparin-Related Bleeding
Campbell et al.
Arch Intern Med 1996;156:857-860.
ABSTRACT
Comparison of Sustained Antithrombotic Effects of Inhibitors of Thrombin and Factor Xa in Experimental Thrombosis
Biemond et al.
Circulation 1996;93:153-160.
ABSTRACT
| FULL TEXT
The Successful Application of a Heparin Nomogram in a Community Hospital
Hollingsworth et al.
Arch Intern Med 1995;155:2095-2100.
ABSTRACT
Appropriate Use of Heparin: Empiric vs Nomogram-Based Dosing
Gunnarsson et al.
Arch Intern Med 1995;155:526-532.
ABSTRACT
A Review of Common Approaches to Heparin Dosing
Hodgman
Journal of Pharmacy Practice 1995;8:39-46.
ABSTRACT
Methods for Standardizing Intravenous Heparin Therapy
Raschke and Reilly
Arch Intern Med 1995;155:117-117.
ABSTRACT
Use of a Standardized Heparin Nomogram to Achieve Therapeutic Anticoagulation After Thrombolytic Therapy in Myocardial Infarction
Flaker et al.
Arch Intern Med 1994;154:1492-1496.
ABSTRACT
Physician-Guided Treatment Compared With a Heparin Protocol for Deep Vein Thrombosis
Elliott et al.
Arch Intern Med 1994;154:999-1004.
ABSTRACT
Computer-Assisted Dosing of Heparin: Management With a Pharmacy-Based Anticoagulation Service
Kershaw et al.
Arch Intern Med 1994;154:1005-1011.
ABSTRACT
Pseudotumor Cerebri: A Complication of Catheter-Induced Subclavian Vein Thrombosis
Birdwell et al.
Arch Intern Med 1994;154:808-811.
ABSTRACT
